Delcath Systems Inc (DCTH)
5.40
+0.20
(+3.85%)
USD |
NASDAQ |
May 01, 16:00
5.40
0.00 (0.00%)
After-Hours: 16:00
Delcath Systems Research and Development Expense (Quarterly): 4.709M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.709M |
| September 30, 2023 | 4.662M |
| June 30, 2023 | 3.555M |
| March 31, 2023 | 4.576M |
| December 31, 2022 | 4.431M |
| September 30, 2022 | 4.065M |
| June 30, 2022 | 5.606M |
| March 31, 2022 | 4.481M |
| December 31, 2021 | 3.619M |
| September 30, 2021 | 2.955M |
| June 30, 2021 | 3.497M |
| March 31, 2021 | 3.707M |
| December 31, 2020 | 2.744M |
| September 30, 2020 | 3.26M |
| June 30, 2020 | 2.223M |
| March 31, 2020 | 2.974M |
| December 31, 2019 | 2.701M |
| September 30, 2019 | 1.778M |
| June 30, 2019 | 1.714M |
| March 31, 2019 | 3.298M |
| December 31, 2018 | 5.764M |
| September 30, 2018 | 4.106M |
| June 30, 2018 | 4.089M |
| March 31, 2018 | 5.692M |
| December 31, 2017 | 3.376M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.279M |
| June 30, 2017 | 2.518M |
| March 31, 2017 | 2.321M |
| December 31, 2016 | 2.473M |
| September 30, 2016 | 2.686M |
| June 30, 2016 | 1.945M |
| March 31, 2016 | 1.344M |
| December 31, 2015 | 2.374M |
| September 30, 2015 | 1.683M |
| June 30, 2015 | 1.45M |
| March 31, 2015 | 0.979M |
| December 31, 2014 | 0.667M |
| September 30, 2014 | 0.683M |
| June 30, 2014 | 1.492M |
| March 31, 2014 | 1.457M |
| December 31, 2013 | 2.049M |
| September 30, 2013 | 2.178M |
| June 30, 2013 | 3.992M |
| March 31, 2013 | 4.469M |
| December 31, 2012 | 5.626M |
| September 30, 2012 | 5.254M |
| June 30, 2012 | 8.204M |
| March 31, 2012 | 7.131M |
| December 31, 2011 | 9.84M |
| September 30, 2011 | 6.437M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.714M
Minimum
Jun 2019
5.606M
Maximum
Jun 2022
3.540M
Average
3.555M
Median
Jun 2023
Research and Development Expense (Quarterly) Benchmarks
| Star Equity Holdings Inc | -- |
| Exact Sciences Corp | 114.92M |
| Illumina Inc | 341.00M |
| CytoSorbents Corp | 4.096M |
| Progyny Inc | -- |